Blunted blades: new CRISPR-derived technologies to dissect microbial multi-drug resistance and biofilm formation.
Christopher GagerAna Lidia Flores-MirelesPublished in: mSphere (2024)
The spread of multi-drug-resistant (MDR) pathogens has rapidly outpaced the development of effective treatments. Diverse resistance mechanisms further limit the effectiveness of our best treatments, including multi-drug regimens and last line-of-defense antimicrobials. Biofilm formation is a powerful component of microbial pathogenesis, providing a scaffold for efficient colonization and shielding against anti-microbials, which further complicates drug resistance studies. Early genetic knockout tools didn't allow the study of essential genes, but clustered regularly interspaced palindromic repeat inference (CRISPRi) technologies have overcome this challenge via genetic silencing. These tools rapidly evolved to meet new demands and exploit native CRISPR systems. Modern tools range from the creation of massive CRISPRi libraries to tunable modulation of gene expression with CRISPR activation (CRISPRa). This review discusses the rapid expansion of CRISPRi/a-based technologies, their use in investigating MDR and biofilm formation, and how this drives further development of a potent tool to comprehensively examine multi-drug resistance.
Keyphrases
- biofilm formation
- genome wide
- pseudomonas aeruginosa
- drug resistant
- staphylococcus aureus
- candida albicans
- multidrug resistant
- escherichia coli
- dna methylation
- gene expression
- crispr cas
- genome editing
- acinetobacter baumannii
- microbial community
- gram negative
- systematic review
- copy number
- emergency department
- quantum dots